SCHEMBL7207428

SCHEMBL7207428

CCc1noc([C@H]2O[C@@H](n3cnc4c(NC(CC)CC)nc(NC5CCC(N)CC5)nc43)[C@H](O)[C@@H]2O)n1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 12/20 0.51
CDK2 P24941 4/20 0.45
CCNB2 O95067 3/20 0.45
CCNE2 O96020 3/20 0.45
CDK1 P06493 3/20 0.45
CDK4 P11802 3/20 0.45
CCNB1 P14635 3/20 0.45
CCND1 P24385 3/20 0.45
CCNE1 P24864 3/20 0.45
CCNB3 Q8WWL7 3/20 0.45
ADORA3 P0DMS8 3/20 0.43
ADORA1 P30542 3/20 0.43
ADORA2B P29275 3/20 0.43
FLT3 P36888 2/20 0.41
SRC P12931 1/20 0.41
PDGFRA P16234 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7207432 1.00 ADORA2A (0.51) ADORA2ACDK2CCNB2CCNE2CDK1
Formic Acid SCHEMBL7204946 0.96 ADORA2A (0.50) ADORA2ACDK2CCNB2CCNE2CDK1
Formic Acid SCHEMBL7204951 0.96 ADORA2A (0.50) ADORA2ACDK2CCNB2CCNE2CDK1
SCHEMBL7569540 0.93 ADORA2A (0.51) ADORA2AADORA3ADORA1ADORA2B
SCHEMBL7208424 0.92 ADORA2A (0.52) ADORA2ACDK2CCNB2CCNE2CDK1
SCHEMBL7208427 0.92 ADORA2A (0.52) ADORA2ACDK2CCNB2CCNE2CDK1
SCHEMBL7204948 0.91 ADORA2A (0.47) ADORA2ACDK2CCNB2CCNE2CDK1
Formic Acid SCHEMBL7211355 0.90 ADORA2A (0.48) ADORA2AADORA3ADORA1ADORA2B
SCHEMBL7204947 0.90 ADORA2A (0.45) ADORA2ACDK2CCNB2CCNE2CDK1
Formic Acid SCHEMBL7202128 0.89 ADORA2A (0.51) ADORA2ACDK2CCNB2CCNE2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6610665-B1 Treatment of inflammatory diseases, asthma or chronic obstructive pulmonary disease SMITHKLINE BEECHAM CORPORATION 2003-08-26 US claimed
EP-1056759-B1 2-(PURIN-9-YL) -TETRAHYDROFURAN-3, 4-DIOL DERIVATIVES GLAXO GROUP LTD (GB) 2002-09-04 EP claimed